ImmunoglobuliN in the Treatment of Encephalitis (IgNiTE): protocol for a multicentre randomised controlled trial

ImmunoglobuliN in the Treatment of Encephalitis (IgNiTE): protocol for a multicentre randomised controlled trial

Introduction Infectious and immune-mediated encephalitides are important but under-recognised causes of morbidity and mortality in childhood, with a 7% death rate and up to 50% morbidity after prolonged follow-up. There is a theoretical basis for ameliorating the immune response with intravenous imm...

Full description

Saved in:
Bibliographic Details
Main Authors: R Kneen, M Lim, A Vincent, A J Pollard, W K Chong, L-M Yu, M A Iro, M Sadarangani, M Absoud, C A Clark, A Easton, V Gray, M Pike, T Solomon, L Willis
Format: Article
Language:English
Published: BMJ Publishing Group 2016-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/6/11/e012356.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items